Global Local Anesthesia Drugs Market


Posted July 16, 2021 by gmeglobalmarket

Global Local Anesthesia Drugs Market Size, Trends & Analysis - Forecasts to 2026
 
Global Local Anesthesia Drugs Market Size-Forecasts to 2026

As per the research conducted by GME, the Local Anesthesia Drugs Market is estimated to be valued at USD 5.60 billion in 2021 and is projected to reach USD 6.75 billion by 2026 at a CAGR of 3.8%. Growing patient pool, rising geriatric population, increasing technological advancements, and soaring inclination for innovative drugs will support the market growth.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Local Anesthesia Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/local-anesthesia-drugs-market-3378

By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application (Injectable, Surface Anesthetic), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

Key Market Insights
• The expanding research on local anesthetics is also propelling market advancement.
• The lidocaine product segment is foreseen to lead because of its widespread use as a topical and intravenous anesthetic.
• The injectable application segment is presumed to predominate they are ubiquitously used in a variety of surgical operations.
• Growing surgeries demand for post-surgery pain relief the hospital pharmacy is leading to its supremacy.
• The market for North America is presumed to predominate owing to the supportive reimbursement facilities for medical instruments and devices.
• Fresenius Kabi USA, LLC, Pfizer Inc., Advanced Pharma, Inc., Akorn, Inc. Teva Pharmaceutical Industries Ltd., Akorn, Inc., Glenmark Pharmaceuticals, Inc., Baxter International, Inc., AstraZeneca PLC, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Hikma Pharmaceuticals PLC, Hospira, Inc., AbbVie Inc., Fresenius Se & Co. Kgaa, and Novartis AG, are the key players in the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/local-anesthesia-drugs-market-3378

Product Outlook (Revenue, USD Billion, 2021-2026)
• Bupivacaine
• Ropivacaine
• Lidocaine
• Chloroprocaine
• Prilocaine
• Benzocaine

Application Outlook (Revenue, USD Billion, 2021-2026)
• Injectable
• Surface Anesthetic

Distribution Channel Outlook (Revenue, USD Billion, 2021-2026)
• Hospital Pharmacy
• Pharmacy Stores
• Other

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: [email protected]
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Global Market Estimates Research & Consultants
Phone +1 60266673238
Business Address U.S. Office
652 5th Ave Apt 2
Country United States
Categories Health
Tags covid19 impact on local anesthesia drugs market , local anesthesia drugs , local anesthesia drugs market opportunities , local anesthesia drugs market research report , local anesthesia drugs market share , local anesthesia drugs market statistics
Last Updated July 16, 2021